UCB.BR acquires RARX for $48/sh cash—112% premium to yesterday’s lose: https://finance.yahoo.com/news/ucb-agrees-acquire-ra-pharmaceuticals-110000368.html The nominal deal value is $2.1B. CC at 9am ET.